Ductal carcinoma in situ (DCIS) is a non-invasive breast cancer.
In DCIS, the abnormal cells are contained in the milk ducts (canals that carry milk from the lobules to the nipple openings during breastfeeding). It is called “in situ” (which means "in place") because the cells have not left the milk ducts to invade nearby breast tissue.
DCIS is also called intraductal (within the milk ducts) carcinoma. You may also hear the terms “pre-invasive” or “pre-cancerous” to describe DCIS.
DCIS can be found alone or with invasive breast cancer.
If DCIS is diagnosed with invasive breast cancer, treatment and prognosis are based on the invasive breast cancer (not the DCIS).
Learn about treatment for early breast cancer.
Treatment for DCIS usually involves surgery with or without radiation therapy.
After surgery and radiation therapy, some women may take hormone therapy (tamoxifen or an aromatase inhibitor).
With treatment, prognosis is usually excellent.
Learn more about treatment for DCIS.
DCIS is non-invasive, but without treatment, the abnormal cells could turn into invasive cancer over time.
At this time, health care providers cannot predict which cases of DCIS will progress to invasive breast cancer and which will not. So, almost every case of DCIS is treated.
After treatment for DCIS there is still a small risk of:
These risks are higher with lumpectomy plus radiation therapy than with mastectomy .
However, overall survival is the same after either treatment . With close follow-up, invasive breast cancer is usually caught early and can be treated successfully.
Learn about treatment for DCIS.
Learn about lumpectomy.
Learn about radiation therapy.
Learn about mastectomy.
Learn More | Current Article
*Please note, the information provided within Komen Perspectives articles is only current as of the date of posting. Therefore, some information may be out of date at this time.
Facts for Life: Ductal Carcinoma in Situ
Breast Cancer 101 - Stage 0 Treatments
How has having breast cancer changed your outlook?